Having employers and accountable care organizations agree on expectations is necessary for better alignment of care offered, explained Brian Marcotte, president and CEO of the National Business Group on Health.
Having employers and accountable care organizations agreeing on expectations is necessary for better alignment of care offered, explained Brian Marcotte, president and CEO of the National Business Group on Health.
Transcripts (slightly modified)
Does there need to be better alignment between what employers are looking for from an accountable care organization (ACO) and what ACOs are offering?
I think it’s really more about agreeing on what expectations are and making sure expectations are aligned. So, an early-stage ACO is going to focus primarily on the 5% of the population that drives 50% of the cost—the better care coordination, better management within the provider community, and the specialty community. What does that mean for the rest of the population? It doesn’t mean much.
So, from an employer perspective, I just want to know where this ACO is from a developmental standpoint, so I know what to communicate to my members. If it’s an early-stage ACO, an employer who has chronic conditions and an employee who is fairly healthy, is not going to seem much different. A later-stage ACO, who’s doing more outreach to chronic patients and moderate-risk patients—well there is something different there. So, it’s really aligning expectations.
There’s nothing wrong with an early-stage ACO, it’s just understanding that it’s early stage, and you will see things different from that then you will from an ACO that’s more mature.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More